A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder in which molecular pathology, cellular stress and network dysfunction accumulate over many years before dementia becomes clinically ...

Signal transduction and gene regulation are at the heart of cell and developmental biology, driving cell fate decisions and tissue homeostasis. In cancer, ...

AbstractNon apoptotic cell death programs particularly ferroptosis and cuproptosis are transforming how we understand cancer ...

Aging, at its most fundamental level, is a molecular process. Chemical marks on the genome shift and lose fidelity over time, ...

Adani Mundra Airport has commenced scheduled commercial flight operations with Star Air's inaugural service from Goa. The ...

Russia’s Burevestnik cruise missile—codenamed "Skyfall" by NATO—represents a dramatic leap in nuclear weapons technology.

TAIPEI, June 23, 2026 /PRNewswire/ -- Sparkling Sciences Co., Ltd., under TOMO YUME Group, announced it has obtained international INCI certification for iPSC Exosome and completed Kyoto University's ...

The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one of the longevity field's most promising theories.

The first participant has been treated in a landmark clinical trial of cellular reprogramming, which aims to rejuvenate aging ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.